Initial monotherapy safe in type 2 diabetes but must be abandoned quickly if ineffective

ORLANDO – Starting a patient with newly diagnosed type 2 diabetes mellitus on a single agent is a reasonable approach, but leaving them too long on monotherapy that proves ineffective is...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news